Introduced Version
Senate Bill 664 History
| Email
Key: Green = existing Code. Red = new code to be enacted
Senate Bill No. 664
(By Senators Oliverio and Kessler)
____________
[Introduced March 23, 2009; referred to the Committee on Health
and Human Resources.]
____________
A BILL to amend and reenact §30-7-15a and §30-7-15
b of the Code of
West Virginia, 1931, as amended, all relating to expanding
prescriptive authority of advanced nurse practitioners.
Be it enacted by the Legislature of West Virginia:
That §30-7-15a and §30-7-15
b of the Code of West Virginia,
1931, as amended, be amended and reenacted, all to read as follows:
ARTICLE 7. REGISTERED PROFESSIONAL NURSES.
§30-7-15a.
Prescriptive authority for prescription drugs;
coordination with Board of Pharmacy.
(a) The board may, in its discretion, authorize an advanced
nurse practitioner to prescribe prescription drugs in a
collaborative relationship with a physician licensed to practice in
West Virginia and in accordance with applicable state and federal
laws. An authorized advanced nurse practitioner may write or sign
prescriptions or transmit prescriptions verbally or by other means of communication.
(b) For purposes of this section an agreement to a
collaborative relationship for prescriptive practice between a
physician and an advanced nurse practitioner shall be set forth in
writing. Verification of such the agreement shall be filed with
the board by the advanced nurse practitioner. The board shall
forward a copy of such the verification to the Board of Medicine.
Collaborative agreements shall include, but are not be limited to,
the following:
(1) Mutually agreed upon written guidelines or protocols for
prescriptive authority as it applies to the advanced nurse
practitioner's clinical practice;
(2) Statements describing the individual and shared
responsibilities of the advanced nurse practitioner and the
physician pursuant to the collaborative agreement between them;
(3) Periodic and joint evaluation of prescriptive practice;
and
(4) Periodic and joint review and updating of the written
guidelines or protocols.
(c) The board shall promulgate legislative rules in accordance
with the provisions of chapter twenty-nine-a of this code governing
the eligibility and extent to which an advanced nurse practitioner
may prescribe drugs. Such rules shall provide, at a minimum, a
state formulary classifying those categories of drugs which shall not be prescribed by advanced nurse practitioners, including, but
not limited to, Schedules I and II of the Uniform Controlled
Substances Act, anticoagulants, antineoplastics,
radio-pharmaceuticals and general anesthetics. Drugs listed under
schedule III shall be limited to a seventy-two hour supply without
refill.
(d) The board shall consult with other appropriate boards for
the development of the formulary
is allowed to have prescriptive
authority. The rules shall allow, at a minimum, those categories
of drugs which may not be prescribed by advance nurse
practitioners, including but not limited to, Schedule I of the
Uniform Controlled Substances Act, nontopical antineoplastics and
general anesthetics. Drugs listed under Schedule III shall be
limited to not more than a ninety-day supply with up to three
thirty day refills, including but not limited to, Schedule III
anti-depressants and analgesics.
(e) (d) The board shall transmit to the Board of Pharmacy a
list of all advanced nurse practitioners with prescriptive
authority. The list shall include:
(1) The name of the authorized advanced nurse practitioner;
(2) The prescriber's identification number assigned by the
board; and
(3) The effective date of prescriptive authority.
§30-7-15b. Eligibility for prescriptive authority; application; fee.
An advanced nurse practitioner who applies for authorization
to prescribe drugs shall:
(a) Be licensed and certified in West Virginia as an advanced
nurse practitioner holding a baccalaureate degree in science or the
arts
as a registered professional nurse in West Virginia and
recognized in West Virginia as an advanced nurse practitioner with
a graduate degree in nursing from a school of nursing accredited by
a nationally recognized nursing accreditation body approved by the
United States Department of Education;
(b) Not be less than eighteen years of age;
(c) Provide the board with evidence of successful completion
of forty-five contact hours of education in pharmacology and
clinical management of drug therapy under a program approved by the
board, fifteen hours of which shall be completed within the
two-year period immediately before the date of application;
(d) Provide the board with evidence that he or she is a person
of good moral character and not addicted to alcohol or the use of
controlled substances; and
(e) Submit a completed, notarized application to the board,
accompanied by a fee of $125.
NOTE: The purpose of this bill is to expand the prescriptive
authority of advanced nurse practitioners by allowing them to
prescribe a ninety-day supply with up to three thirty day renewals.
Current law allows a seventy-two hour supply without refill.
Strike-throughs indicate language that would be stricken from
the present law, and underscoring indicates new language that would
be added.